PCHISTO Stock Latest News
Private CompaniesHistoSonics Highlights CE Mark Milestone and Clinical Engagement at ESSO Conference2d agoHISTO
Private CompaniesHistoSonics Promotes Business-Focused Webinar on Histotripsy Program Development2d agoHISTO
Private CompaniesHistoSonics Showcases Edison Histotripsy System at IHPBA Conference2w agoHISTO
Private CompaniesSummit Activity Underscores Growing Clinical Ecosystem Around HistoSonics2w agoHISTO
Private CompaniesHistoSonics Showcases Edison Histotripsy System at Major Medical Conferences1M agoHISTO
Private CompaniesHistoSonics – Weekly Recap3M agoHISTO
Private CompaniesHistoSonics Highlights Edison Histotripsy System at Robotic Surgery Meeting3M agoHISTO- Private CompaniesHistoSonics Expands Histotripsy Training Center Presence in Hong Kong3M agoHISTO
Private CompaniesHistoSonics Gains CE Mark for Edison System, Paving Way for European Commercialization3M agoHISTOPrivate CompaniesPatient Story Highlights Non-Invasive Histotripsy Use in Metastatic Cancer3M agoHISTO
Private CompaniesHistoSonics Secures New Financing Round to Advance Histotripsy Development4M agoHISTO
Private CompaniesHistoSonics Showcases Edison Histotripsy System at American Transplant Congress4M agoHISTO- Private CompaniesHistoSonics Gains TFDA Clearance for Edison System in Taiwan5M agoHISTO
Private CompaniesHistoSonics Gains Taiwan TFDA Clearance for Edison System, Advancing Asia Expansion5M agoHISTO
Private CompaniesHistoSonics Advances Kidney Tumor Strategy With FDA De Novo Filing and TIME Recognition5M agoHISTOPrivate CompaniesHistoSonics Pursues FDA De Novo Pathway to Extend Edison Histotripsy to Kidney Tumors5M agoHISTO
Private CompaniesHistoSonics Pursues FDA De Novo Pathway to Extend Edison Histotripsy to Kidney Tumors5M agoHISTO